Use of vitamins C and E as a prophylactic therapy to prevent postoperative atrial fibrillation

International Journal of Cardiology

Volumn 138, Issue 3, 2010, Pages 221-228

  Rodrigo, Ramón ^a   Vinay, José ^a   Castillo, Rodrigo ^a   Cereceda, Mauricio ^b   Asenjo, René ^b   Zamorano, Jaime ^b   Araya, Julia ^a   Castillo Koch, Rodrigo ^b   Espinoza, Juan ^b   Larraín, Ernesto ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Ischemia reperfusion; Oxidative stress; Postoperative atrial fibrillation; Vitamin C; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ALTEPLASE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CARRIER PROTEIN; CARVEDILOL; CATALASE; CREATINE KINASE MM; GAP JUNCTION PROTEIN; GLUTATHIONE PEROXIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ION CHANNEL; MITOCHONDRIAL DNA; NITRIC OXIDE SYNTHASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHOPHYLL;

ADRENERGIC ACTIVITY; APOPTOSIS; ATHEROSCLEROSIS; CARDIOVERSION; CARDITIS; CLINICAL TRIAL; CYTOSOL; DNA DAMAGE; DRUG POTENTIATION; EXTRACORPOREAL CIRCULATION; GENETIC TRANSCRIPTION; HEART ATRIUM CONTRACTILITY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MEMBRANE CONDUCTANCE; MOLECULE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; TACHYCARDIA; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ASCORBIC ACID; ATRIAL FIBRILLATION; HUMANS; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; POSTOPERATIVE COMPLICATIONS; VITAMIN E;

EID: 74649085071     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.04.043     Document Type: Review

References (109)

1. Korantzopoulos P., Kolettis T., Siogas K., and Goudevenos J. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit 9 (2003) 225-229
2. Lin P.H., Lee S.H., Su C.P., and Wei Y.H. : Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation. Free Radic Biol Med 35 (2003) 1310-1318
3. Fuster V., Rydén L.E., Cannom D.S., et al. Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114 (2006) e257-e354
4. Hogue C.h., and Hyder M. Atrial fibrillation after cardiac operation: risks, mechanisms, and treatment. Ann Thorac Surg 69 (2000) 300-306
5. Wu Z.K., Iivainen T., Pehkonen E., Laurikka J., Zhang S., and Tarkka M.R. Fibrillation in patients subjected to coronary artery bypass grafting. J Thorac Cardiovasc Surg 126 (2003) 1477-1482
6. Maisel W.H., Rawn J.D., and Stevenson W.G. Atrial fibrillation after cardiac surgery. Ann Intern Med 135 (2001) 1061-1073
7. Mathew J.P., Fontes M.L., Tudor I.C., et al. Multicenter study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. J Am Med Assoc 291 (2004) 1720-1729
8. Mitchell L.B. Prophylactic therapy to prevent atrial arrhythmia after cardiac surgery. Curr Opin Cardiol 22 (2007) 18-24
9. Hammwöhner M., Smid J., Lendeckel U., and Goette A. New drugs for atrial fibrillation. J Interv Card Electrophysiol 23 (2008) 15-21
10. Neuman R.B., Bloom H.L., and Shukrullah I. Oxidative stress markers are associated with persistent atrial fibrillation. Clin Chem 53 (2007) 1652-1657
11. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
12. Corradi D., Callegari S., Maestri R., et al. Heme oxygenase-1 expression in the left atrial myocardium of patients with chronic atrial fibrillation related to mitral valve disease: its regional relationship with structural remodeling. Hum Pathol 39 (2008) 1162-1171
13. Rodrigo R., Castillo R., Cereceda M., Asenjo R., Zamorano J., and Araya J. Non-hypoxic preconditioning of myocardium against postoperative atrial fibrillation: mechanism based on enhancement of the antioxidant defense system. Med Hypotheses 69 (2007) 1242-1248
14. Rodrigo R., Cereceda M., Castillo R., et al. Prevention of atrial fibrillation following cardiac surgery: basis for a novel therapeutic strategy based on non-hypoxic myocardial preconditioning. Pharmacol Ther 118 (2008) 104-127
15. Olshansky B. Interrelationships between the autonomic nervous system and atrial fibrillation. Prog Cardiovasc Dis 48 (2005) 57-78
16. Dilaveris P., Giannopoulos G., Synetos A., and Stefanadis C. The role of renin angiotensin system blockade in the treatment of atrial fibrillation. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 387-403
17. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
18. Goette A., Arndt M., Röcken C., et al. Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283 (2002) 264-272
19. Brundel B.J., Ausma J., van Gelder I.C., et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation. Cardiovasc Res 54 (2002) 380-389
20. Chung M.K., Martin D.O., Sprecher D., et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
21. de Bakker J.M., Ho S.Y., and Hocini M. Basic and clinical electrophysiology of pulmonary vein ectopy. Cardiovasc Res 54 (2002) 287-294
22. Van Wagoner D.R. Recent insights into the pathophysiology of atrial fibrillation. Semin Thorac Cardiovasc Surg 19 (2007) 9-15
23. Aslan O., and Güneri S. [Electrophysiological mechanisms of atrial fibrillation]. Anadolu Kardiyol Derg 2 (2002) 244-252
24. Platonov P.G. Interatrial conduction in the mechanisms of atrial fibrillation: from anatomy to cardiac signals and new treatment modalities. Europace 9 Suppl 6 (2007) vi10-vi16
25. Van Wagoner D.R. Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26 (2003) 1572-1575
26. Van Wagoner D.R. Molecular basis of atrial fibrillation: a dream or a reality?. J Cardiovasc Electrophysiol 14 (2003) 667-669
27. Opie L.H., Commerford P.J., Gersh B.J., and Pfeffer M.A. Controversies in ventricular remodelling. Lancet 367 (2006) 356-367
28. Everett T.H., and Olgin J.E. Atrial fibrosis and the mechanisms of atrial fibrillation. Heart Rhyth 4 (2007) 24-27
29. Polizio A.H., Balestrasse K.B., Yannarelli G.G., et al. Angiotensin II regulates cardiac hypertrophy via oxidative stress but not antioxidant enzyme activities in experimental renovascular hypertension. Hypertens Res 31 (2008) 325-334
30. Murray K.T., Mace L.C., and Yang Z. Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm 4 3 Suppl (2007) S88-90
31. Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 5 (2008) 338-349
32. Mihm M.J., Yu F., Carnes C.A., et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
33. De Vecchi E., Pala M.G., Di Credico G., et al. Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 79 (1998) 242-247
34. Ide T., Tsutsui H., Kinugawa S., et al. Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ Res 86 (2000) 152-157
35. Ukai T., Cheng C.P., Tachibana H., et al. Allopurinol enhances the contractile response to dobutamine and exercise in dogs with pacing-induced heart failure. Circulation 103 (2001) 750-755
36. In: Sies H. (Ed). Oxidative stress: oxidants and anti-oxidants (1991), London Academic Press
37. Nagano T. Chemical and biochemical studies on reactivities, formations and toxicities of reactive oxygen species. Yakugaku Zasshhi 111 (1991) 103-119
38. Kim Y.M., Guzik T.J., Zhang Y.H., et al. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 97 (2005) 629-636
39. Kim Y.M., Kattach H., Ratnatunga C., Pillai R., Channon K.M., and Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 51 (2008) 68-74
40. Paravicini T.M., and Touyz R.M. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 Suppl 2 (2008) S170-S180
41. Heller R., Unbehaun A., Schellenberg B., Mayer B., Werner-Felmayer G., and Werner E.R. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276 (2001) 40-47
42. Werner E.R., Gorren A.C., Heller R., Werner-Felmayer G., and Mayer B. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp Biol Med 228 (2003) 1291-1302
43. Förstermann U., and Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113 (2006) 1708-1714
44. Kim H.Y., Kim O.H., and Sung M.K. Effects of phenol-depleted and phenol-rich diets on blood markers of oxidative stress, and urinary excretion of quercetin and kaempferol in healthy volunteers. J Am Coll Nutr 22 (2003) 217-223
45. Aviram M., Kaplan M., Rosemblat M., and Fuhrman B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb Exp Pharmacol 170 (2005) 263-300
46. Newaz M.A., Yousefipour Z., and Nawal N.N. Modulation of nitric oxide synthase activity in brain, liver, and blood vessels of spontaneously hypertensive rats by ascorbic acid: protection from free radical injury. Clin Exp Hypertens 6 (2005) 497-508
47. Guney M., Oral B., Demirin H., Karahan N., Mungan T., and Delibas N. Protective effects of vitamins C and E against endometrial damage and oxidative stress in fluoride intoxication. Clin Exp Pharmacol Physiol 34 (2007) 467-474
48. Ramlawi B., Otu H., Mieno S., et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 84 (2007) 1166-1172
49. Kim Y.H., Lim D.S., Lee J.H., et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med 35 (2003) 336-349
50. Ohki R., Yamamoto K., Ueno S., et al. Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int J Cardiol 102 (2005) 233-238
51. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
52. Abdelhadi R.H., Gurm H.S., Van Wagoner D.R., and Chung M.K. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 93 (2004) 1176-1178
53. Bruins P., te Velthuis H., Yazdanbakhsh A.P., et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 96 (1997) 3542-3548
54. Lamm G., Auer J., Weber T., Berent R., Ng C., and Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 20 (2006) 51-55
55. Pavlović D., D{stroke}ord{stroke}ević V., and Kocić G. A "cross-talk" between oxidative stress and redox cell signalling. Med Biol 2 (2002) 131-137
56. Chandra J., Samali A., and Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29 (2000) 323-333
57. Liakopoulos O.J., Schmitto J.D., Kazmaier S., et al. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery. Ann Thorac Surg 84 (2007) 110-118
58. Halonen J., Halonen P., Järvinen O., et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 297 (2007) 1562-1567
59. Goldstein R.N., Ryu K., Khrestian C., van Wagoner D.R., and Waldo A.L. Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. J Cardiovasc Electrophysiol 19 (2008) 74-81
60. Bukowska A., Schild L., Keilhoff G., et al. Mitochondrial dysfunction and redox signaling in atrial tachyarrhythmia. Exp Biol Med 233 (2008) 558-574
61. Kawakami M., and Okabe E. Superoxide anion radical-triggered Ca2+ release from cardiac sarcoplasmic reticulum through ryanodine receptor Ca2+ channel. Mol Pharmacol 53 (1998) 497-503
62. Eloff B.C., Lerner D.L., Yamada K.A., Schuessler R.B., Saffitz J.E., and Rosenbaum D.S. High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res 51 (2001) 681-690
63. Peters N.S., Coromilas J., Severs N.J., and Wit A.L. Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 95 (1997) 988-996
64. Sawaya S.E., Rajawat Y.S., Rami T.G., et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol 292 (2007) H1561-H1567
65. Severs N.J., Bruce A.F., Dupont E., and Rothery S. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80 (2008) 9-19
66. Duffy H.S., and Wit A.L. Is there a role for remodeled connexins in AF? No simple answers. J Mol Cell Cardiol 44 (2008) 4-13
67. Ramachandran S., Xie L.H., John S.A., Subramaniam S., and Lal R. A novel role for connexin hemichannel in oxidative stress and smoking-induced cell injury. PLoS ONE 2 (2007) e712
68. Korantzopoulos P., Kountouris E., Kolettis T., and Siogas K. Anti-inflammatory and antioxidant actions of statins may favorably affect atrial remodeling in atrial fibrillation. Am J Cardiol 93 (2004) 1200
69. Liu T., Li G., Korantzopoulos P., and Goudevenos J.A. Statins and prevention of atrial fibrillation in patients with heart failure. Int J Cardiol 134 (2009) 336-341
70. Ozaydin M., Peker O., Erdogan D., et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 29 (2008) 625-631
71. Das K.C., and Misra H.P. Antiarrhythmic agents. Scavengers of hydroxyl radicals and inhibitors of NADPH-dependent lipid peroxidation in bovine lung microsomes. J Biol Chem 267 (1992) 19172-19178
72. Heller R., Werner-Felmayer G., and Werner E.R. Alpha-tocopherol and endothelial nitric oxide synthesis. Ann N Y Acad Sci 1031 (2004) 74-85
73. Heller R., Werner-Felmayer G., and Werner E.R. Antioxidants and endothelial nitric oxide synthesis. Eur J Clin Pharmacol 62 (2006) 21-28
74. Rodrigo R., Guichard C., and Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam Clin Pharmacol 21 (2007) 111-127
75. Krinsky N.I., and Johnson E.J. Carotenoid actions and their relation to health and disease. Mol Aspects Med 26 (2005) 459-516
76. Lauver D.A., Lockwood S.F., and Lucchesi B.R. Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J Pharmacol Exp Ther 314 (2005) 686-692
77. Mason R.P. Molecular basis of differences among statins and a comparison with antioxidant vitamins. Am J Cardiol 98 (2006) 34-41
78. McNulty H., Jacob R.F., and Mason R.P. Biologic activity of carotenoids related to distinct membrane physicochemical interactions. Am J Cardiol 101 (2008) 20-29
79. Levine M., Rumsey S.C., Daruwala R., Park J.B., and Wang Y. Criteria and recommendations for vitamin C intake. JAMA 281 (1999) 1415-1423
80. Wang X., and Quinn P.J. The location and function of vitamin E in membranes. Mol Membr Biol 17 (2000) 143-156
81. Gille L., Staniek K., and Nohl H. Effects of tocopheryl quinone on the heart: model experiments with xanthine oxidase, heart mitochondria, and isolated perfused rat hearts. Free Radic Biol Med 30 (2001) 865-876
82. Gille L., Gregor W., Staniek K., and Nohl H. Redox-interaction of alpha-tocopheryl quinone with isolated mitochondrial cytochrome bc1 complex. Biochem Pharmacol 68 (2004) 373-381
83. Pignatelli P., Sanguigni V., Paola S.G., Lo Coco E., Lenti L., and Violi F. Vitamin C inhibits platelet expression of CD40 ligand. Free Radic Biol Med 38 (2005) 1662-1666
84. Ulker S., McKeown P.P., and Bayraktutan U. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 41 (2003) 534-539
85. Taddei S., Virdis A., Ghiadoni L., and Salvetti A. Endothelial dysfunction in hypertension: fact or fancy?. J Cardiovasc Pharmacol 32 Suppl 3 (1998) S41-47
86. Newaz M.A., Nawal N.N., Rohaizan C.H., Muslim N., and Gapor A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 12 (1999) 839-844
87. Wu F., Schuster D.P., Tyml K., and Wilson J.X. Ascorbate inhibits NADPH oxidase subunit p47phox expression in microvascular endothelial cells. Free Radic Biol Med 42 (2007) 124-131
88. Wu D., Liu L., Meydani M., and Meydani S.N. Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2. J Nutr 135 (2005) 1847-1853
89. Rinne T., Mutschler E., Wimmer-Greinecker G., Moritz A., and Olbrich H.G. Vitamins C and E protect isolated cardiomyocytes against oxidative damage. Int J Cardiol 75 (2000) 275-281
90. Qin F., Shite J., and Liang C.S. Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways. Am J Physiol Heart Circ Physiol 285 (2003) 822-832
91. Guaiquil V.H., Golde D.W., Beckles D.L., Mascareno E.J., and Siddiqui M.A. Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med 37 (2004) 1419-1429
92. Zhou H., Ma J.H., Zhang P.H., and Luo A.T. Vitamin C pretreatment attenuates hypoxia-induced disturbance of sodium currents in guinea pig ventricular myocytes. J Membr Biol 211 (2006) 81-87
93. Walker M.K., Vergely C., Lecour S., Abadie C., Maupoil V., and Rochette L. Vitamin E analogues reduce the incidence of ventricular fibrillations and scavenge free radicals. Fundam Clin Pharmacol 12 (1998) 164-172
94. Poliukhovich G.S., Vasil'eva L.P., Maslova G.T., Boboriko T.L., and Speranskiǐ S.D. [Efficacy of various antioxidants in experimental ischemia and myocardial infarct in the rat]. Vopr Med Khim 37 (1991) 54-56
95. Shite J., Qin F., Mao W., Kawai H., Stevens S.Y., and Liang C. Antioxidant vitamins attenuate oxidative stress and cardiac dysfunction in tachycardia-induced cardiomyopathy. J Am Coll Cardiol 38 (2001) 1734-1740
96. Qin F., Yan C., Patel R., Liu W., and Dong E. Vitamins C and E attenuate apoptosis, beta-adrenergic receptor desensitization, and sarcoplasmic reticular Ca2+ ATPase downregulation after myocardial infarction. Free Radic Biol Med 40 (2006) 1827-1842
97. Costa V.A., Vianna L.M., Aguila M.B., and Mandarim-de-Lacerda C.A. Alpha-tocopherol supplementation favorable effects on blood pressure, blood viscosity and cardiac remodeling of spontaneously hypertensive rats. J Nutr Biochem 16 (2005) 251-256
98. Carnes C.A., Cheng M.K., Nakayama T., et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of post-operative atrial fibrillation. Circ Res 89 (2001) 32-38
99. Korantzopoulos P., Kolettis T.M., Kountouris E., et al. Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation. Int J Cardiol 102 (2005) 321-326
100. Hicks J.J., Montes-Cortes D.H., Cruz-Dominguez M.P., Medina-Santillan R., and Olivares-Corichi I.M. Antioxidants decrease reperfusion induced arrhythmias in myocardial infarction with ST-elevation. Front Biosci 12 (2007) 2029-2037
101. Eslami M., Badkoubeh R.S., Mousavi M., et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 34 (2007) 268-274
102. Marín F., Pascual D.A., Roldán V., et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 97 (2006) 55-60
103. Patti G., Chello M., Candura D., et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 114 (2006) 1455-1461
104. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J 29 (2008) 1548-1559
105. Merritt J.C., Niebauer M., Tarakji K., Hammer D., and Mills R.M. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol 92 (2003) 735-736
106. Acikel S., Bozbas H., Gultekin B., et al. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery. Int J Cardiol 126 (2008) 108-113
107. Haghjoo M., Saravi M., Hashemi M.J., et al. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol. Heart Rhythm 4 (2007) 1170-1174
108. Solomon A.J., Greenberg M.D., Kilborn M.J., and Katz N.M. Amiodarone versus a beta-blocker to prevent atrial fibrillation after cardiovascular surgery. Am Heart J 142 (2001) 811-815
109. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150